Compare SCLX & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | REKR |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 151.6M |
| IPO Year | N/A | N/A |
| Metric | SCLX | REKR |
|---|---|---|
| Price | $17.70 | $1.86 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 119.6K | ★ 3.1M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,360,000.00 | ★ $49,028,000.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | $749.70 | $22.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $3.60 | $0.62 |
| 52 Week High | $34.27 | $3.42 |
| Indicator | SCLX | REKR |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 45.53 |
| Support Level | $18.34 | $1.79 |
| Resistance Level | $20.62 | $1.80 |
| Average True Range (ATR) | 2.14 | 0.12 |
| MACD | -0.28 | 0.02 |
| Stochastic Oscillator | 1.86 | 63.89 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.